First Command Advisory Services’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BBIO
First Command Advisory Services's BBIO Position: Q3 2026 in Review
First Command Advisory Services opened a new position in BridgeBio Pharma (BBIO) in Q3 2026: 5 shares worth $329. The stake represents ﹤0.01% of the portfolio and ranks #1372 among its holdings.
468 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.
- First Command Advisory Services held 5 shares of BridgeBio Pharma worth $329 as of Q3 2026.
- BridgeBio Pharma was a new First Command Advisory Services position in Q3 2026.
- BridgeBio Pharma made up ﹤0.01% of First Command Advisory Services's portfolio in Q3 2026, its #1372 holding.
- 468 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.
Based on First Command Advisory Services's 13F filing for Q3 2026, filed 5 Nov 2026.